These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20521869)

  • 21. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial.
    Severino MG; Cortellini G; Bonadonna P; Francescato E; Panzini I; Macchia D; Campi P; Spadolini I; Canonica WG; Passalacqua G
    J Allergy Clin Immunol; 2008 Jul; 122(1):44-8. PubMed ID: 18468672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients.
    Tabar AI; Anda M; Bonifazi F; Bilò MB; Leynadier F; Fuchs T; Ring J; Galvain S; André C
    Int Arch Allergy Immunol; 2006; 141(4):369-76. PubMed ID: 16943675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latex immunotherapy: state of the art.
    Nettis E; Delle Donne P; Di Leo E; Fantini P; Passalacqua G; Bernardini R; Canonica GW; Ferrannini A; Vacca A
    Ann Allergy Asthma Immunol; 2012 Sep; 109(3):160-5. PubMed ID: 22920069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Perspectives in the treatment of allergy to latex: immunotherapy].
    Tabar AI; Gómez B; Arroabarren E; Rodríguez M; Lázaro I; Anda M
    An Sist Sanit Navar; 2003; 26 Suppl 2():97-102. PubMed ID: 13679968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
    Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Failure of sublingual immunotherapy to treat latex allergy. A report of a case].
    Morfin Maciel BM; Castillo Morfin BM
    Rev Alerg Mex; 2008; 55(2):76-81. PubMed ID: 19058485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study.
    Feliziani V; Lattuada G; Parmiani S; Dall'Aglio PP
    Allergol Immunopathol (Madr); 1995; 23(5):224-30. PubMed ID: 8526180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life outcomes with sublingual immunotherapy.
    Wise SK; Woody J; Koepp S; Schlosser RJ
    Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
    Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
    J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot study.
    Voltolini S; Troise C; Incorvaia C; Bignardi D; Di Cara G; Marcucci F; La Grutta S; Frati F
    Curr Med Res Opin; 2010 Jan; 26(1):37-40. PubMed ID: 19895362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual desensitization: a new approach to latex allergy problem.
    Patriarca G; Nucera E; Pollastrini E; Roncallo C; Buonomo A; Bartolozzi F; De Pasquale T; Gasbarrini G; Schiavino D
    Anesth Analg; 2002 Oct; 95(4):956-60, table of contents. PubMed ID: 12351276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.